C12Q 2523/10
Reactions characterised by treatment of reaction samples: characterised by chemical treatment
Official title: Characterised by chemical treatment
C12Q2523/10 (Reactions characterised by treatment of reaction samples: characterised by chemical treatment) appears on 96 US grants and 196 published applications in this corpus.
Search patents in C12Q- Granted patents
- 96
- Published applications
- 196
- Assignees
- 120
- Inventors
- 439
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 2 |
| 2004 | 2 | 4 |
| 2005 | 1 | 2 |
| 2006 | 0 | 3 |
| 2007 | 1 | 2 |
| 2008 | 1 | 12 |
| 2009 | 1 | 7 |
| 2010 | 3 | 10 |
| 2011 | 1 | 12 |
| 2012 | 0 | 8 |
| 2013 | 2 | 2 |
| 2014 | 3 | 6 |
| 2015 | 7 | 5 |
| 2016 | 3 | 4 |
| 2017 | 5 | 11 |
| 2018 | 1 | 17 |
| 2019 | 4 | 12 |
| 2020 | 14 | 19 |
| 2021 | 4 | 19 |
| 2022 | 11 | 16 |
| 2023 | 12 | 9 |
| 2024 | 7 | 8 |
| 2025 | 9 | 1 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12Q 2523/125BisulfiteIndexing code49
- C12Q 2523/101Crosslinking agentsIndexing code12
- C12Q 2523/109Chemical ligation between nucleic acidsIndexing code10
- C12Q 2523/107Chemical cleaving agentsIndexing code8
- C12Q 2523/115Oxidising agentsIndexing code8
- C12Q 2523/113Denaturating agentsIndexing code5
- C12Q 2523/119Renaturing agentsIndexing code0
Recent patents
- Method and system for constructing sequencing library on the basis of methylated DNA target region, and use thereof29 Sep 2026US 12,747,470 B2MGI Tech Co., Ltd.
- Methods for genome assembly and haplotype phasing1 Sep 2026US 12,725,678 B2The Regents of the University of California
- Chromosome conformation markers of autism spectrum disorder28 Jul 2026US 12,692,543 B2Oxford Biodynamics PLC
- Systems and methods for tumor fraction estimation from small variants16 Dec 2025US 12,497,662 B2Grail, LLC
- Methods for RNA analysis9 Dec 2025US 12,492,425 B2CureVac AG
- Methods for rna analysis1 Oct 2026US 2026/0297648 A1CureVac AG
- Methods for the Epigenetic Analysis of DNA, Particularly Cell-Free DNA24 Sep 2026US 2026/0286421 A1Clearnote Health, Inc.
- Application of epigenetic chromsomal interactions in cancer diagnostics27 Aug 2026US 2026/0250783 A1Oxford Biodynamics PLC
- Detecting ovarian cancer19 Mar 2026US 2026/0078450 A1Exact Sciences Corporation
- Methods and formulations for denaturing dna2 Jan 2025US 2025/0002973 A1Illumina, Inc.
Most cited
By later US patents
- Enhancing specificity of analyte binding87US 11,702,698 B210x Genomics, Inc. · 2023
- Processing particle-containing samples84US 8,679,831 B2HandyLab, Inc. · 2014
- Method of detection of prostate cancer80US 7,524,633 B2The Johns Hopkins University School of Medicine · 2009
- Processing particle-containing samples63US 9,670,528 B2HandyLab, Inc. · 2017
- DNA sequence with non-fluorescent nucleotide reversible terminators and cleavable label modified nucleotide terminators62US 9,115,163 B2The Trustees of Columbia University in the City of New York · 2015